RAPT Therapeutics(RAPT)
SOUTH SAN FRANCISCO, CA
Biotechnology1 H-1B visas (FY2023)Focus: Immune-targeted cancer therapies
RAPT Therapeutics is a life sciences company focused on Immune-targeted cancer therapies.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
FLX925
Acute Myeloid LeukemiaClinical Trials (1)
NCT02335814First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
Phase 114C RPT193
Healthy Male SubjectsClinical Trials (1)
NCT06087978Study of RPT193 in Healthy Adult Male Subjects
Phase 1RPT193
Atopic DermatitisClinical Trials (1)
NCT04271514A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis
Phase 1FLX475
Advanced CancerRPT193
AsthmaClinical Trials (1)
NCT05935332Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma
Phase 2RPT193
Atopic DermatitisClinical Trials (1)
NCT05399368An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
Phase 2Phase 2
Clinical Trials (1)
NCT07220811Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
Phase 2FLX475
Advanced MelanomaClinical Trials (1)
NCT04894994FLX475 in Combination With Ipilimumab in Advanced Melanoma
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2015
Portfolio: 7 clinical trials
H-1B (2023): 1 approval
SEC Filings: 2 available
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub